Updates are available Correction dated 2022-07-29
Click to view Correction: https://doi.org/10.1007/s12035-022-02975-4
-
Authors
Mondal, Koushik
Porter, Hunter
Cole, Jerome II
Pandya, Hemang K.
Basu, Sandip K.
Khanam, Sufiya
Chiu, Chi-Yang
Shah, Vinay
Stephenson, Daniel J.
Chalfant, Charles E.
Mandal, Nawajes https://orcid.org/0000-0003-4489-7748
-
Funding
Funding for this research was provided by:
National Institutes of Health (EY031316)
National Institutes of Health (EY022071)
National Institutes of Health (AI139072)
National Institutes of Health (GM137578)
National Institutes of Health (GM137394)
U.S. Department of Veterans Affairs (I01BX004893)
U.S. Department of Veterans Affairs (IBX001792)
U.S. Department of Veterans Affairs (IK6BX004603)
Congressionally Directed Medical Research Programs (W81XWH-20-1-0900)
- License Information
-
More Information
Article History
Received: 11 January 2022
Accepted: 1 April 2022
First Online: 15 April 2022
Change Date: 29 July 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12035-022-02975-4
Declarations
:
: Human study was approved by University of Oklahoma Institutional Review Board for the Protection of Human Subjects; IRB#: 5218; Approval Date: 02/27/2015Study Title: Sphingolipids, Autoimmune Diseases and Retinopathies.
: Human study and consent to publish was approved by University of Oklahoma; Institutional Review Board for the Protection of Human Subjects; IRB#: 5218; Approval Date: 02/27/2015.
: All the authors have seen the manuscript and approved for publication.
: Human study was approved by University of Oklahoma; Institutional Review Board for the Protection of Human Subjects; IRB#: 5218; Approval Date: 02/27/2015; Study Title: Sphingolipids, Autoimmune Diseases and Retinopathies.<b>Animals:</b> Animal studies approved by UTHSC IACUC committee. Approval # 19–0104.
: Obtained for all participants according to the approved IRB#: 5218; protocol at the University of Oklahoma. Approval Date: 02/27/2015.Study Title: Sphingolipids, Autoimmune Diseases and Retinopathies.
: None.
